Wednesday, November 23, 2016 11:15:15 AM
1) There is nothing outrageous, misleading or fraudulent. The fact is that the clinical trials are complete and undergoing final review at the hospital. This is fact and not just mere speculation.
2) The FDA did not ban Sucanon as you continue to falsely claim. The FDA denied the application for over-the-counter sales because it is a drug. The FDA invited Roth to apply for aproval as a drug. This is well documented in the FDA letter.
3) You say "...$147 in the bank is proof of all the myriad of false press releases...". The size of the bank account is meaningless and proves nothing.
Release of clnical trial results has been a long time in coming, but it is coming. The patient investors will be rewarded.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM